These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8487662)

  • 21. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
    Cummings MH; Watts GF; Umpleby AM; Hennessy TR; Naoumova R; Slavin BM; Thompson GR; Sönksen PH
    Diabetologia; 1995 Aug; 38(8):959-67. PubMed ID: 7589883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women.
    Granfone A; Campos H; McNamara JR; Schaefer MM; Lamon-Fava S; Ordovas JM; Schaefer EJ
    Metabolism; 1992 Nov; 41(11):1193-8. PubMed ID: 1435290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus.
    Schwartz EA; Koska J; Mullin MP; Syoufi I; Schwenke DC; Reaven PD
    Atherosclerosis; 2010 Sep; 212(1):217-22. PubMed ID: 20557887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of insulin on cholesterol synthesis in type II diabetes patients.
    Scoppola A; Testa G; Frontoni S; Maddaloni E; Gambardella S; Menzinger G; Lala A
    Diabetes Care; 1995 Oct; 18(10):1362-9. PubMed ID: 8721938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of one week juice fasting on lipid metabolism: a cohort study in healthy subjects.
    Huber R; Nauck M; Lüdtke R; Scharnagl H
    Forsch Komplementarmed Klass Naturheilkd; 2003 Feb; 10(1):7-10. PubMed ID: 12624474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.
    Wägner AM; Ordóñez-Llanos J; Arcelus R; Bonet R; Jorba O; Sánchez-Quesada JL; Alonso E; Julve J; Pérez A
    Metabolism; 2003 Aug; 52(8):1038-42. PubMed ID: 12898470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance.
    Fujiwara R; Kutsumi Y; Hayashi T; Nishio H; Koshino Y; Shimada Y; Nakai T; Miyabo S
    Am J Cardiol; 1995 Jan; 75(2):122-6. PubMed ID: 7810485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.
    Shen DC; Fuh MM; Shieh SM; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1991 Sep; 73(3):503-10. PubMed ID: 1874929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid profile and its relation to fasting insulin level in non-insulin dependent diabetes mellitus (NIDDM).
    Uddin F; Miah AK
    Bangladesh Med Res Counc Bull; 1995 Aug; 21(2):64-72. PubMed ID: 8815864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Glucose tolerance, function of pancreatic B-cells and blood lipids in "healthy" offspring of parents with conjugal type 2 diabetes].
    Jaskólska-Ładosz K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
    Pol Arch Med Wewn; 2000; 103(3-4):153-61. PubMed ID: 11236242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM.
    Borkman M; Chisholm DJ; Furler SM; Storlien LH; Kraegen EW; Simons LA; Chesterman CN
    Diabetes; 1989 Oct; 38(10):1314-9. PubMed ID: 2676659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of omega-3 fatty acids on intravascular lipolysis of very-low-density lipoproteins in humans.
    Kasim-Karakas SE; Herrmann R; Almario R
    Metabolism; 1995 Sep; 44(9):1223-30. PubMed ID: 7666799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal cholesterol distribution among lipoprotein fractions in normolipidemic patients with mild NIDDM.
    Abate N; Vega GL; Garg A; Grundy SM
    Atherosclerosis; 1995 Nov; 118(1):111-22. PubMed ID: 8579621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency.
    Cuneo RC; Salomon F; Watts GF; Hesp R; Sönksen PH
    Metabolism; 1993 Dec; 42(12):1519-23. PubMed ID: 8246764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications.
    Vanizor B; Orem A; Karahan SC; Kiran E; Erem C; Aliyazicioğlu R; Uydu HA
    Diabetes Res Clin Pract; 2001 Oct; 54(1):33-9. PubMed ID: 11532328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fasting hypertriglyceridemia in noninsulin-dependent diabetes mellitus is an important predictor of postprandial lipid and lipoprotein abnormalities.
    Lewis GF; O'Meara NM; Soltys PA; Blackman JD; Iverius PH; Pugh WL; Getz GS; Polonsky KS
    J Clin Endocrinol Metab; 1991 Apr; 72(4):934-44. PubMed ID: 2005221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.